Literature DB >> 27826030

Revisiting Epidemiologic Features of Achalasia.

Guy E Boeckxstaens1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27826030     DOI： 10.1016/j.cgh.2016.11.002

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  3 in total

1.  Tailoring Therapy for Achalasia.

Authors:  Joel E Richter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-05

2.  Development of quality indicators for the diagnosis and management of achalasia.

Authors:  Afrin N Kamal; Priya Kathpalia; Fouad Otaki; Albert J Bredenoord; Donald O Castell; John O Clarke; Gary W Falk; Ronnie Fass; C Prakash Gyawali; Peter J Kahrilas; Philip O Katz; David A Katzka; John E Pandolfino; Roberto Penagini; Joel E Richter; Sabine Roman; Edoardo Savarino; George Triadafilopoulos; Michael F Vaezi; Marcelo F Vela; David A Leiman
Journal:  Neurogastroenterol Motil       Date:  2021-03-15       Impact factor: 3.960

3.  Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia.

Authors:  Janette Furuzawa-Carballeda; Lise Boon; Gonzalo Torres-Villalobos; Fernanda Romero-Hernández; Estefania Ugarte-Berzal; Erik Martens; Jennifer Vandooren; Vasily Rybakin; Enrique Coss-Adame; Miguel Valdovinos; David Velazquez-Fernández; Ghislain Opdenakker
Journal:  Clin Transl Gastroenterol       Date:  2018-11-19       Impact factor: 4.488
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.